Related Experiment Video

Updated: Jul 24, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Clinical trials of reducing low-density lipoprotein concentrations

B M Rifkind1

  • 1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.

Endocrinology and Metabolism Clinics of North America
|October 24, 1998
PubMed

Insights

New statin drug trials confirm their effectiveness in reducing cardiovascular events and mortality. These powerful medications are safe and beneficial for diverse patient groups, including those with diabetes and hypertension.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Low-density lipoprotein (LDL) cholesterol is causally linked to atherosclerotic coronary heart disease (CHD).
  • Previous LDL-lowering trials showed CHD rate reductions but raised concerns about long-term toxicity.

Purpose of the Study:

  • To evaluate the efficacy and safety of statin therapy in reducing cardiovascular events.
  • To assess the impact of statins across various patient subgroups and for stroke prevention.

Main Methods:

  • Analysis of recent clinical trials investigating statin drugs for cardiovascular risk reduction.
  • Inclusion of both primary and secondary prevention studies.
  • Review of angiographic data assessing effects on coronary and carotid lesions.

Main Results:

  • Statin therapy uniformly reduced CHD mortality and morbidity, as well as total mortality.
  • Significant decrease in the need for revascularization procedures observed.
  • Benefits were consistent across subgroups including women, diabetics, and hypertensives; statins also aided stroke prevention.

Conclusions:

  • Statin drugs represent a highly effective and safe therapeutic class for managing atherosclerotic coronary heart disease.
  • These findings support the widespread use of statins in both primary and secondary cardiovascular prevention strategies.
  • Statin therapy demonstrates a positive impact on vascular lesions, contributing to improved patient outcomes.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...